Further FDA Reform Bills Being Introduced

31 March 1996

Three new Republican bills dealing with reform of the US Food and Drug Administration are being readied for introduction this month on the House side of the Capitol. The three separate measures would cover drugs and biotechnology, medical devices and food, according to the sponsors.

As the Marketletter was going to press, it was hoped the bills would be introduced within the month of March, have their hearings in April and eventually also win Senate approval so they would be on the President's desk by the end of the year, said Representative James Greenwood, who is heading the reform effort.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight